Sustained release excipients market to reach $2.3 billion by 2030 at 8.9% CAGR, driven by growing demand for personalized medicine and patient-specific drug formulations.
Read More
Sulfonamide market to reach $3.95 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of skin infections linked to antibiotic-resistant bacteria.
Read More
Subcutaneous immunoglobulin (scig) market to reach $25.71 billion by 2030 at 12.0% CAGR, driven by rising prevalence of secondary immunodeficiency and neurological disorders.
Read More
Subcutaneous drug delivery devices market to reach $42.42 billion by 2030 at 7.3% CAGR, driven by increasing prevalence of diabetes and cardiovascular diseases worldwide.
Read More
Stress supplements market to reach $3.76 billion by 2030 at 9.3% CAGR, driven by rising prevalence of stress-related disorders due to growing work pressures and fast-paced lifestyles.
Read More
Strabismus treatment apparatus market to reach $2.25 billion by 2030 at 6.4% CAGR, driven by rising healthcare expenditures and improved access to non-surgical vision correction devices.
Read More
Sterile injectables cdmo market to reach $10.91 billion by 2030 at 10.3% CAGR, driven by increasing demand for biologics and biosimilars requiring specialized sterile manufacturing.
Read More
Stem cell therapy market to reach $16.12 billion by 2030 at 11.3% CAGR, driven by increasing development of personalized medicine and expansion of regenerative treatment applications.
Read More
Stay-c for feed market to reach $6.96 billion by 2030 at 8.4% CAGR, driven by increase in demand for meat and poultry products and growing need for stable vitamin c feed additives.
Read More
Sprycel market to reach $2.65 billion by 2030 at 4.3% CAGR, driven by increasing prevalence of leukemia and rising healthcare expenditure supporting access to targeted cancer therapies.
Read More